Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05037812 · ClinicalTrials.gov registry record · Early Phase 1
Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures
A Early Phase 1 study of Tibial Plateau Fractures, sponsored by University of Utah.
- Active
- Registry status
- Early Phase 1
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05037812: Active Early Phase 1 study of Tibial Plateau Fractures, sponsored by University of Utah.
NCT05037812 is a Early Phase 1 study of Tibial Plateau Fractures that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 150 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (183% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05037812, a Early Phase 1 study of Tibial Plateau Fractures, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators goal of the proposed research study is to determine the effectiveness of periarticular multimodal analgesia in the setting of tibial plateau fractures. Effectiveness of the multimodal analgesia is defined as lower pain scores.
Primary Outcome
VAS pain score (0 no pain - 10 severe pain)
Conditions Studied
Interventions
- DRUG Saline injection
- DRUG Multimodal injections
Study Locations (1)
Utah
- University of Utah Orthopaedic Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-03-25 |
| Est. Completion | 2026-03 |
| Phase | Early Phase 1 |
What the registry record for NCT05037812 still lists
NCT05037812 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (183% higher).
The record links to 1 condition, with Tibial Plateau Fractures appearing as the primary indexed condition, and to 2 interventions - of which Saline injection is the first listed.
NCT05037812 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT05037812 about?
NCT05037812 is a clinical study titled "Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures". The investigators goal of the proposed research study is to determine the effectiveness of periarticular multimodal analgesia in the setting of tibial plateau fractures. Effectiveness of the multimodal analgesia is defined as lower pain scores.
What is the current status of trial NCT05037812?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 150 participants. The study started on 2019-03-25. Estimated completion is 2026-03.
What conditions does trial NCT05037812 study?
This clinical trial studies the following conditions: Tibial Plateau Fractures.
What interventions are being tested in trial NCT05037812?
The interventions under investigation include: Saline injection (DRUG), Multimodal injections (DRUG).
Who is sponsoring clinical trial NCT05037812?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05037812 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tibial Plateau Fractures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05037812's enrollment target sits among peer trials
150 100th of 2000 higher than 1,895 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI